Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector
In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Inje...
Gespeichert in:
Veröffentlicht in: | Drug Delivery System 2023/11/25, Vol.38(5), pp.445-449 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng ; jpn |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 449 |
---|---|
container_issue | 5 |
container_start_page | 445 |
container_title | Drug Delivery System |
container_volume | 38 |
creator | Kitahara, Kaori Mori, Masakazu Fujimura, Katsumasa Aoki, Toru Seto, Kohei Asakura, Toshinari |
description | In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors. |
doi_str_mv | 10.2745/dds.38.445 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3054699398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054699398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2235-daec4742d549ff428e5f7fe64cae9474d8dadd862c2b010fae15a1ec4ebad5a63</originalsourceid><addsrcrecordid>eNo90EtOwzAUBVALgUQpTFhBJGZIKf4mzoBBoXwqFXXQMrbc-LkkSuNipwjYAAtgh6wEo5aOLL977CddhM4JHtCciytjwoDJAefiAPWIlCSlOaOHqIcLwlKBcXaMTkKoMeYxJD00G8EbNG69grZLnE2ms_nwZjiZ_nx_JeO2hrJzPtGtSeB9HS-6q1wbEhuHTy5G1SeYZFQtq043e3-KjqxuApztzj56vr-b3z6mk-nD-HY4SUtKmUiNhpLnnBrBC2s5lSBsbiHjpYYiBkYabYzMaEkXmGCrgQhN4htYaCN0xvroYvvv2rvXDYRO1W7j27hSMSx4VhSskFFdblXpXQgerFr7aqX9hyJY_ZWmYmmKSRVLi_h6i-vQ6SXsqfZdVTbwT8XO7-fli_YKWvYLUHJ3iw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054699398</pqid></control><display><type>article</type><title>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>Kitahara, Kaori ; Mori, Masakazu ; Fujimura, Katsumasa ; Aoki, Toru ; Seto, Kohei ; Asakura, Toshinari</creator><creatorcontrib>Kitahara, Kaori ; Mori, Masakazu ; Fujimura, Katsumasa ; Aoki, Toru ; Seto, Kohei ; Asakura, Toshinari</creatorcontrib><description>In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors.</description><identifier>ISSN: 0913-5006</identifier><identifier>EISSN: 1881-2732</identifier><identifier>DOI: 10.2745/dds.38.445</identifier><language>eng ; jpn</language><publisher>Kawasaki: THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM</publisher><subject>Digital Injector ; Injection ; Injectors ; Motorized ; Motorized Digital Injector ; OSTABALO ; Osteoporosis ; Pharmaceuticals ; PHC ; Product development ; TEIJIN</subject><ispartof>Drug Delivery System, 2023/11/25, Vol.38(5), pp.445-449</ispartof><rights>2023 The Japan Society of Drug Delivery System</rights><rights>Copyright Japan Science and Technology Agency 2023</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1877,27905,27906</link.rule.ids></links><search><creatorcontrib>Kitahara, Kaori</creatorcontrib><creatorcontrib>Mori, Masakazu</creatorcontrib><creatorcontrib>Fujimura, Katsumasa</creatorcontrib><creatorcontrib>Aoki, Toru</creatorcontrib><creatorcontrib>Seto, Kohei</creatorcontrib><creatorcontrib>Asakura, Toshinari</creatorcontrib><title>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</title><title>Drug Delivery System</title><addtitle>DDS</addtitle><description>In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors.</description><subject>Digital Injector</subject><subject>Injection</subject><subject>Injectors</subject><subject>Motorized</subject><subject>Motorized Digital Injector</subject><subject>OSTABALO</subject><subject>Osteoporosis</subject><subject>Pharmaceuticals</subject><subject>PHC</subject><subject>Product development</subject><subject>TEIJIN</subject><issn>0913-5006</issn><issn>1881-2732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo90EtOwzAUBVALgUQpTFhBJGZIKf4mzoBBoXwqFXXQMrbc-LkkSuNipwjYAAtgh6wEo5aOLL977CddhM4JHtCciytjwoDJAefiAPWIlCSlOaOHqIcLwlKBcXaMTkKoMeYxJD00G8EbNG69grZLnE2ms_nwZjiZ_nx_JeO2hrJzPtGtSeB9HS-6q1wbEhuHTy5G1SeYZFQtq043e3-KjqxuApztzj56vr-b3z6mk-nD-HY4SUtKmUiNhpLnnBrBC2s5lSBsbiHjpYYiBkYabYzMaEkXmGCrgQhN4htYaCN0xvroYvvv2rvXDYRO1W7j27hSMSx4VhSskFFdblXpXQgerFr7aqX9hyJY_ZWmYmmKSRVLi_h6i-vQ6SXsqfZdVTbwT8XO7-fli_YKWvYLUHJ3iw</recordid><startdate>20231125</startdate><enddate>20231125</enddate><creator>Kitahara, Kaori</creator><creator>Mori, Masakazu</creator><creator>Fujimura, Katsumasa</creator><creator>Aoki, Toru</creator><creator>Seto, Kohei</creator><creator>Asakura, Toshinari</creator><general>THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM</general><general>Japan Science and Technology Agency</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20231125</creationdate><title>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</title><author>Kitahara, Kaori ; Mori, Masakazu ; Fujimura, Katsumasa ; Aoki, Toru ; Seto, Kohei ; Asakura, Toshinari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2235-daec4742d549ff428e5f7fe64cae9474d8dadd862c2b010fae15a1ec4ebad5a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>Digital Injector</topic><topic>Injection</topic><topic>Injectors</topic><topic>Motorized</topic><topic>Motorized Digital Injector</topic><topic>OSTABALO</topic><topic>Osteoporosis</topic><topic>Pharmaceuticals</topic><topic>PHC</topic><topic>Product development</topic><topic>TEIJIN</topic><toplevel>online_resources</toplevel><creatorcontrib>Kitahara, Kaori</creatorcontrib><creatorcontrib>Mori, Masakazu</creatorcontrib><creatorcontrib>Fujimura, Katsumasa</creatorcontrib><creatorcontrib>Aoki, Toru</creatorcontrib><creatorcontrib>Seto, Kohei</creatorcontrib><creatorcontrib>Asakura, Toshinari</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Drug Delivery System</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kitahara, Kaori</au><au>Mori, Masakazu</au><au>Fujimura, Katsumasa</au><au>Aoki, Toru</au><au>Seto, Kohei</au><au>Asakura, Toshinari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</atitle><jtitle>Drug Delivery System</jtitle><addtitle>DDS</addtitle><date>2023-11-25</date><risdate>2023</risdate><volume>38</volume><issue>5</issue><spage>445</spage><epage>449</epage><pages>445-449</pages><issn>0913-5006</issn><eissn>1881-2732</eissn><abstract>In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors.</abstract><cop>Kawasaki</cop><pub>THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM</pub><doi>10.2745/dds.38.445</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0913-5006 |
ispartof | Drug Delivery System, 2023/11/25, Vol.38(5), pp.445-449 |
issn | 0913-5006 1881-2732 |
language | eng ; jpn |
recordid | cdi_proquest_journals_3054699398 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese |
subjects | Digital Injector Injection Injectors Motorized Motorized Digital Injector OSTABALO Osteoporosis Pharmaceuticals PHC Product development TEIJIN |
title | Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A21%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20OSTABALO%E2%93%87%20Injector%20and%20expectations%20for%20Motorized%20Digital%20Injector&rft.jtitle=Drug%20Delivery%20System&rft.au=Kitahara,%20Kaori&rft.date=2023-11-25&rft.volume=38&rft.issue=5&rft.spage=445&rft.epage=449&rft.pages=445-449&rft.issn=0913-5006&rft.eissn=1881-2732&rft_id=info:doi/10.2745/dds.38.445&rft_dat=%3Cproquest_cross%3E3054699398%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054699398&rft_id=info:pmid/&rfr_iscdi=true |